404 studies found for:    PLAT-01
Show Display Options
Rank Status Study
1 Active, not recruiting A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia
Condition: B Cell Leukemia
Intervention: Biological: Autologous CD19 CAR+ EGFTt + T cells
2 Completed Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion
Conditions: Thrombosis;   Acute Coronary Syndrome;   Myocardial Infarction;   Stroke
Intervention: Drug: revacept (PR-15)
3 Completed Effect of Ibuprofen, Paracetamol and Their Combination on Radical Oxygen Species (ROS) Production
Condition: Pain
Interventions: Drug: Ibuprofen;   Drug: Paracetamol (acetaminophen) 1000 mg;   Drug: Paracetamol + ibuprofen
4 Recruiting Phase I, Arteriocyte Magellan MAR01 Therapy - Compartment Syndrome and Battlefield Trauma
Condition: Compartment Syndrome
Intervention: Device: Magellan®
5 Recruiting GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
Condition: Coronary Artery Disease (CAD)
Interventions: Drug: Ticagrelor;   Drug: Acetylsalicylic Acid;   Drug: Clopidogrel
6 Terminated
Has Results
Interventional Management of Stroke (IMS) III Trial
Condition: Stroke
Interventions: Drug: IV rt-PA alone;   Other: endovascular therapy
7 Unknown  Intra Bone Marrow Injection Of Unrelated Cord Blood Cells
Condition: Hematologic Diseases
Intervention: Procedure: Intrabone Marrow Injection
8 Recruiting Leaders Free Japan
Condition: Coronary Disease
Interventions: Procedure: Percutaneous coronary intervention (PCI);   Drug: Dual Anti Platelet Therapy
9 Completed MIS+rtPA for ICH Evacuation
Condition: Intracerebral Hemorrhage
Interventions: Drug: MIS+Cathflo Activase (drug);   Procedure: Intraoperative stereotactic CT-Guided Endoscopic Surgery
10 Completed Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy
Conditions: Hodgkin's Disease;   Non-Hodgkin Lymphomas;   Multiple Myelomas
Intervention: Drug: lenograstim
11 Completed Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage
Condition: Cerebral Hemorrhage
Intervention: Drug: Recombinant Tissue Plasminogen Activator (rt-PA)
12 Completed
Has Results
Optimal Platelet Dose Strategy for Management of Thrombocytopenia
Condition: Thrombocytopenia
Interventions: Procedure: Medium Dose Prophylactic Platelet Transfusions;   Procedure: Lower Dose Prophylactic Platelet Transfusions;   Procedure: Higher Dose Prophylactic Platelet Transfusions
13 Completed Platelets for Acute Wound Healing
Condition: Wounds
Intervention: Device: autologous platelet gel
14 Recruiting Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Device: Transcranial ultrasound as an adjunctive therapy to tPA;   Drug: Standard of care tPA therapy for acute ischemic stroke
15 Recruiting Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics
Condition: Liver Cirrhosis
Interventions: Other: Coagulogram-based protocol;   Other: Thromboelastometry-based protocol;   Other: Restrictive strategy
16 Recruiting Study to Assess Efficacy and Safety of Bone Marrow Derived Stem Cells in Patients With Critical Limb Ischemia
Condition: Critical Limb Ischemia
Intervention: Biological: ASCT01 (Autologous Stem Cell Transplantation)
17 Recruiting SITS (Safe Implementation of Treatments in Stroke) Open Artery by Thrombectomy in Acute Occlusive Stroke Study
Condition: Ischemic Stroke
Interventions: Device: Stent retriever endovascular device for thrombectomy;   Drug: Intravenous thrombolysis by alteplase (Actilyse)
18 Completed Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)
Condition: Acute Ischemic Stroke
Intervention: Device: Rev-01
19 Terminated Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery
Conditions: Hemorrhage;   Postoperative Blood Loss
Interventions: Drug: Desmopressin;   Drug: Placebo
20 Completed Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients
Condition: Coronary Arteriosclerosis
Interventions: Drug: modified-release dipyridamole/aspirin;   Drug: aspirin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years